JADE BIOSCIENCES INC (JBIO:NASDAQ)

$17.65 -0.1 (-0.5634%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed JADE BIOSCIENCES INC (JBIO:NASDAQ) News Sources

Companies Like Jade Biosciences (NASDAQ:JBIO) Are In A Position To Invest In Growth

28-03-2026

yahoo.com

Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer

22-04-2026

yahoo.com

Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

23-04-2026

yahoo.com

Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update

07-05-2026

yahoo.com

Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy

26-05-2026

yahoo.com

Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody

26-05-2026

yahoo.com

Assessing Jade Biosciences (JBIO) Valuation After Recent Share Price Weakness And Longer Term Gains

29-05-2026

yahoo.com

Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy

29-05-2026

yahoo.com

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy

01-06-2026

yahoo.com

Jade Biosciences’ JADE101 Delivers Deep IgA Cuts, Clearing Path for Kidney Trials

02-06-2026

marketbeat.com

JADE BIOSCIENCES INC (JBIO:NASDAQ) Sentiment Trend

0 25 50 75 100 76 68 70 68 78 74 63 72 69 83 28-03-2026 22-04-2026 23-04-2026 07-05-2026 26-05-2026 29-05-2026 01-06-2026 02-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

JADE BIOSCIENCES INC (JBIO:NASDAQ) FAQs

toggle

What is the current price of JADE BIOSCIENCES INC (JBIO:NASDAQ)?

The current price of JADE BIOSCIENCES INC (JBIO:NASDAQ) is $17.65.


toggle

JADE BIOSCIENCES INC (JBIO:NASDAQ) absolute price change since previous trading day?

The absolute price change of JADE BIOSCIENCES INC (JBIO:NASDAQ) since the previous trading day is $-0.1.


toggle

JADE BIOSCIENCES INC (JBIO:NASDAQ) percentage price change since previous trading day?

The percentage price change of JADE BIOSCIENCES INC (JBIO:NASDAQ) since the previous trading day is -0.5634%.


toggle

What is the most recent average sentiment score for JADE BIOSCIENCES INC (JBIO:NASDAQ)?

The most recent average sentiment score for JADE BIOSCIENCES INC (JBIO:NASDAQ) is 72 out of 100.


toggle

What is the most recent average sentiment for JADE BIOSCIENCES INC (JBIO:NASDAQ)?

The most recent sentiment for JADE BIOSCIENCES INC (JBIO:NASDAQ) is .


SEC-8K** Filing Available For JADE BIOSCIENCES INC (JBIO:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.